Literature DB >> 30489194

Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.

Changhui Li1, Shouyun Zhang1, Tongguo Qiu2, Yuanji Wang1, David M Ricketts3, Chao Qi4.   

Abstract

OBJECTIVE: To investigate the role and mechanism of action of nicotinamide nucleotide transhydrogenase antisense RNA 1 (NNT-AS1) in osteosarcoma (OS).
METHODS: Bioinformatic analysis suggested miR-320a as potential target of NNT-AS1. Influence of NNT-AS1 overexpression or knockdown on OS cell proliferation, colony-formation, apoptosis, migration and invasion capacity was first investigated. Expression levels of NNT-AS1, miR-320a, beta-catenin, RUNX2, IGF-1R, c-Myc, Cyclin D1 and MMP13 were also evaluated by RT-qPCR and western blotting accordingly. Xenograft models using U2OS and OS-732 cells with different NNT-AS1 gene modifications were constructed for tumor formation assay as well as evaluation of miR-320a, beta-catenin and RUNX2 expression in primary lesion. NNT-AS1-overexpressing U2OS cells and NNT-AS1-knockdown OS-732 cells were subject to miR-320a mimic and inhibitor transfection, respectively, to investigate the miR-320a dependency of the osteosarcoma-promoting role of NNT-AS1.
RESULTS: NNT-AS1 overexpression significantly increased proliferation, survival and mobility of U2OS cells in vitro as well as its tumor formation ability in vivo, while NNT-AS1 knockdown showed opposite effect on OS-732 cells. In both in vitro and in vivo model, NNT-AS1 expression level significantly correlated with that of beta-catenin, RUNX2, IGF-1R, c-Myc, Cyclin D1 and MMP13 as well as Akt phosphorylation level, and inversely correlated with miR-320a expression. Transfection of miR-320a mimic significantly inhibiter the promoting effect of NNT-AS1 on cell proliferation, survival and mobility of U2OS cells, while miR-320 inhibitor partially rescued that of OS-732 cells.
CONCLUSION: NNT-As1 functions as a cancer-promoting lncRNA by downregulating miR-320a, thus increasing the protein expression level of beta-catenin, RUNX2 and IGF-1R as well as activation of Akt in osteosarcoma.

Entities:  

Keywords:  NNT-AS1; long noncoding RNA; miR-320a; osteosarcoma

Mesh:

Substances:

Year:  2018        PMID: 30489194      PMCID: PMC6422455          DOI: 10.1080/15384047.2018.1538612

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  41 in total

1.  miR-320a regulates high mobility group box 1 expression and inhibits invasion and metastasis in hepatocellular carcinoma.

Authors:  Guixiang Lv; Mingjuan Wu; Meijie Wang; Xiaochen Jiang; Jingli Du; Kaili Zhang; Dongliang Li; Ning Ma; Yahui Peng; Lujing Wang; Lingyun Zhou; Weiming Zhao; Yufei Jiao; Xu Gao; Zheng Hu
Journal:  Liver Int       Date:  2017-04-11       Impact factor: 5.828

2.  Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer.

Authors:  Ting Zhang; Ping Zou; Tiejun Wang; Jingying Xiang; Jing Cheng; Daozhen Chen; Jianwei Zhou
Journal:  Tumour Biol       Date:  2016-01-11

Review 3.  Notch Signaling and the Skeleton.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2016-04-13       Impact factor: 19.871

4.  Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.

Authors:  Fangfang Hua; Shanshan Liu; Lihong Zhu; Ning Ma; Shan Jiang; Jun Yang
Journal:  Biomed Pharmacother       Date:  2017-06-13       Impact factor: 6.529

5.  The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis.

Authors:  Batzaya Davaadelger; Ricardo E Perez; Yalu Zhou; Lei Duan; Steven Gitelis; Carl G Maki
Journal:  Cancer Biol Ther       Date:  2017-07-11       Impact factor: 4.742

6.  MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.

Authors:  Yongqiang Dong; Guojun Liang; Bo Yuan; Chaoqun Yang; Rui Gao; Xuhui Zhou
Journal:  Tumour Biol       Date:  2014-11-28

7.  MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin.

Authors:  Jian-Yong Sun; Yi Huang; Ji-Peng Li; Xiang Zhang; Lei Wang; Yan-Ling Meng; Bo Yan; Yong-Qian Bian; Jing Zhao; Wei-Zhong Wang; An-Gang Yang; Rui Zhang
Journal:  Biochem Biophys Res Commun       Date:  2012-03-20       Impact factor: 3.575

8.  MiR-23a functions as a tumor suppressor in osteosarcoma.

Authors:  Yu He; Chunqing Meng; Zengwu Shao; Hong Wang; Shuhua Yang
Journal:  Cell Physiol Biochem       Date:  2014-10-08

9.  Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis.

Authors:  Ye-Bin Lu; Qin Jiang; Man-Yi Yang; Ji-Xiang Zhou; Qi Zhang
Journal:  Oncotarget       Date:  2017-09-28

10.  Effects of the Long Non-Coding RNA HOST2 On the Proliferation, Migration, Invasion and Apoptosis of Human Osteosarcoma Cells.

Authors:  Wei Wang; Xiao Li; Fan-Bin Meng; Zhen-Xing Wang; Ren-Tao Zhao; Chun-Yang Yang
Journal:  Cell Physiol Biochem       Date:  2017-08-31
View more
  14 in total

1.  LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.

Authors:  Dahai Zheng; Daliang Chen; Famu Lin; Xiang Wang; Lenian Lu; Shi Luo; Jianmin Chen; Xiaobing Xu
Journal:  Cell Cycle       Date:  2020-05-18       Impact factor: 4.534

2.  High expression of long non-coding RNA NNT-AS1 facilitates progression of cholangiocarcinoma through promoting epithelial-mesenchymal transition.

Authors:  Yulei Gu; Chao Li; Lili Xiao; Juan Li; Hui Pei; Dong Xu; Yumin Jiang; Xiaofan Zhang; Luanluan Zhang; Kongfei Li; Zhiqiang Zhu; Xiaolong Chen
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.

Authors:  Wenlong He; Yeying Zhang; Shulan Xia
Journal:  Thorac Cancer       Date:  2020-01-10       Impact factor: 3.500

4.  Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.

Authors:  Yulei Gu; Zhiqiang Zhu; Hui Pei; Dong Xu; Yumin Jiang; Luanluan Zhang; Lili Xiao
Journal:  Aging (Albany NY)       Date:  2020-02-05       Impact factor: 5.682

5.  Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.

Authors:  Deyao Wu; Tielong Zhang; Jie Wang; Jian Zhou; Huixing Pan; Ping Qu
Journal:  Aging (Albany NY)       Date:  2019-12-17       Impact factor: 5.682

Review 6.  Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer.

Authors:  Baoqing Chen; Junyan Li; Dongmei Chi; Iman Sahnoune; Steliana Calin; Leonard Girnita; George A Calin
Journal:  Cells       Date:  2019-12-14       Impact factor: 6.600

7.  Long Non-Coding RNA HCG11 Aggravates Osteosarcoma Carcinogenesis via Regulating the microRNA-579/MMP13 Axis.

Authors:  Lili Wang; Jingzhen Zhou; Yong Zhang; Tao Hu; Yongning Sun
Journal:  Int J Gen Med       Date:  2020-12-31

8.  Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes.

Authors:  Chengyao Wan; Jing Wen; Xiaolin Liang; Qiongni Xie; Wenqi Wu; Meiqing Wu; Zhenfang Liu
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

9.  Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.

Authors:  Jianfeng Zhang; Kai Zhang; Yingkui Hou
Journal:  Mol Med Rep       Date:  2020-05-18       Impact factor: 2.952

10.  Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.

Authors:  Chenghao Zhang; Xiaolei Ren; Zhongyue Liu; Chao Tu
Journal:  BMC Cancer       Date:  2020-09-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.